Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 51 results for age-related macular degeneration

  1. Organisational models for AMD diagnosis and management:- What is the long-term effectiveness, in terms of patient-relevant outcomes including visual acuityand quality of life, of different models of care that aim to reduce time from initial presentation to referral, diagnosis and treatment?

    Recommendation ID NG82/2 Question Organisational models for AMD diagnosis and management:- What is the long-term effectiveness, in terms...

    Research recommendation
    Published
    13 November 2018

  2. Past appeals and decisions

    Past technology appraisal appeals and decisions

  3. What is the effectiveness of statin therapy in older people?

    this is important: The UK population is ageing and atherosclerosis is an age-associated process. Few trials assessing cardiovascular...

    Research recommendation
    Published
    9 June 2015

  4. Stopping rules for antiangiogenic treatment for late AMD (wet):- When should anti-vascular endothelial growth factor (VEGF) treatment be suspended or stoppedin people with late AMD (wet)?

    treatment for late AMD (wet):- When should anti-vascular endothelial growth factor (VEGF) treatment be suspended or stoppedin people...

    Research recommendation
    Published
    13 November 2018

  5. Adalimumab and dexamethasone for treating non-infectious uveitis (TA460)

    Evidence-based recommendations on adalimumab (Humira) and dexamethasone (Ozurdex) for treating non-infectious uveitis in adults.

    Technology appraisal guidance
    Published
    26 July 2017
    View recommendations

    Sections for TA460

  6. Radiotherapy for age-related macular degeneration (IPG49)

    We have moved interventional procedures guidance 49 to become HealthTech guidance 24. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  7. Macular translocation for age-related macular degeneration (IPG48)

    This guidance has been updated and replaced by NICE HealthTech guidance 215 and HealthTech guidance 216.

    Withdrawn guidance

  8. Eyemax mono for age-related macular degeneration (MIB154)

    We’ve temporarily withdrawn this medtech innovation briefing to correct factual errors in the text.

    Withdrawn advice

  9. Transpupillary thermotherapy for age-related macular degeneration (IPG58)

    We have moved interventional procedures guidance 58 to become HealthTech guidance 31. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  10. Epiretinal brachytherapy for wet age-related macular degeneration (IPG415)

    Interventional procedures, IPG415 - Issued: December 2011 --> We have moved interventional procedures guidance 415 to become HealthTech guidance 279. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  11. Idebenone for treating visual impairment in Leber's hereditary optic neuropathy in people 12 years and over (TA1093)

    Evidence-based recommendations on idebenone (Raxone) for treating visual impairment in Leber’s hereditary optic neuropathy in people 12 years and over.

    Technology appraisal guidance
    Published
    28 August 2025

    Sections for TA1093

  12. Limited macular translocation for wet age-related macular degeneration (IPG339)

    Interventional procedures, IPG339 - Issued: May 2010 --> We have moved interventional procedures guidance 339 to become HealthTech guidance 215. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  13. Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy (TA307)

    Evidence-based recommendations on aflibercept (Zaltrap) with irinotecan and fluorouracil-based therapy (FOLFIRI) for treating metastatic colorectal cancer after oxaliplatin-based chemotherapy in adults.

    Technology appraisal guidance
    Published
    25 March 2014
    View recommendations

    Sections for TA307

  14. Macular translocation with 360° retinotomy for wet age-related macular degeneration (IPG340)

    We have moved interventional procedures guidance 340 to become HealthTech guidance 216. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  15. Miniature lens system implantation for advanced age-related macular degeneration (IPG565)

    We have moved interventional procedures guidance 565 to become HealthTech guidance 418. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance